Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GeneDx Holdings (WGSWW) Income from Continuing Operations (2020 - 2025)

GeneDx Holdings has reported Income from Continuing Operations over the past 6 years, most recently at 17666000.0 for Q4 2025.

  • Quarterly results put Income from Continuing Operations at 17666000.0 for Q4 2025, down 424.86% from a year ago — trailing twelve months through Dec 2025 was 20973000.0 (up 59.89% YoY), and the annual figure for FY2025 was 21021000.0, up 59.8%.
  • Income from Continuing Operations for Q4 2025 was 17666000.0 at GeneDx Holdings, down from 7588000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for WGSWW hit a ceiling of 32731000.0 in Q3 2021 and a floor of 308719000.0 in Q4 2022.
  • Median Income from Continuing Operations over the past 5 years was 34679000.0 (2021), compared with a mean of 52168250.0.
  • Biggest five-year swings in Income from Continuing Operations: skyrocketed 157.81% in 2021 and later plummeted 668.24% in 2022.
  • GeneDx Holdings' Income from Continuing Operations stood at 40185000.0 in 2021, then plummeted by 668.24% to 308719000.0 in 2022, then skyrocketed by 91.65% to 25784000.0 in 2023, then soared by 121.09% to 5438000.0 in 2024, then plummeted by 424.86% to 17666000.0 in 2025.
  • The last three reported values for Income from Continuing Operations were 17666000.0 (Q4 2025), 7588000.0 (Q3 2025), and 10763000.0 (Q2 2025) per Business Quant data.